Tag

Advertisement

drug-2

Per Norlen Photo Jenny Leyman

Evaxion announces promising Phase 1 data

June 1, 2023

Evaxion Biotech to present promising …

Lyme disease vaccine tested in Sweden

May 31, 2023

A vaccine against Lyme disease …

AnaMar announces positive Phase I data

May 31, 2023

AnaMar has announced results from …

AlzeCure announces Phase IIa clinical study data

May 24, 2023

AlzeCure Pharma has received positive …

spago nanomedical

Spago has submitted application to start Phase I/IIa study

May 23, 2023

Spago Nanomedical has announced that …

First patient dosed in Valo’s Phase I trial

May 23, 2023

Valo Therapeutics has announced that …

First patient dosed in TILT Phase I trial

May 15, 2023

The first patient has been …

Göran Forsberg Photo Håkan Sandbring

Cantargia reports data from combination therapy

May 9, 2023

Cantargia has announced a successful …

New interim data from Alzinova’s ongoing phase 1b study

May 8, 2023

A second planned interim analysis …

Gedea Biotech initiates EpHect Clinical Trial

May 3, 2023

Gedea Biotech has announces that …

Søren Bregenholt

Last patient treated in Alligator/Amphera trial

May 2, 2023

Alligator Bioscience and Amphera have …

BioInvent announces a fourth complete response in Phase 1/2 trial

April 26, 2023

BioInvent International has announced that …

Carlos de Sousa

Ultimovacs adjusts guidance on timeline for INITIUM readout

April 26, 2023

Ultimovacs has adjusted guidance from …

SynAct Pharma completes patient recruitment for Phase 2b study

April 26, 2023

SynAct Pharma has completed patient …

First healthy volunteer dosed in the Herantis’ Phase 1a trial

April 19, 2023

Herantis Pharma has announced the …

Michael Engsig and Agnete Fredriksen

Nykode announces positive final results from its Phase 2 trial

April 19, 2023

Nykode Therapeutics has announced results …

1
2
3